to evaluate the therapeutic efficacy of oral angiotensin-converting inhibition ( ace ) with captopril in chronic normotensive congestive heart failure ( chf ) , acute and cardiocirculatory actions were determined by cardiac catheterization and forearm plethysmography , and ambulatory effects were assessed by echocardiography , nuclear angiography , treadmill exercise , and clinical symptomatology in 10 severe chf patients .
C0006938
captopril
C0018802
chf